Retinal Disorders

The retina is a layer of tissue at the back of the eye that detects light and sends messages to the brain. Retinal disorders affect vision and can even cause blindness.

Programs + Services


Ophthalmology (New England Eye Center)

Ophthalmology (New England Eye Center) at Tufts Medical Center in Boston specializes in the testing and treatment of all types of eye diseases and visual problems.
More information about programs and services

Doctors + Care Team

Jay S. Duker, MD

Jay S. Duker, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): New England Eye Center; Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4604
Fax #: 617-636-4866

Dr. Duker’s part-time clinical practice is limited to medical diseases of the posterior segment of the eye including age-related macular degeneration (AMD), diabetic retinopathy, retinal vascular diseases, posterior segment uveitis and intraocular tumors. He has a particular interest in rare and unusual retinal disorders, especially those connected to systemic disease.

View Full Profile for Jay S. Duker, MD

Caroline R. Baumal, MD

Caroline R. Baumal, MD

Accepting New Patients

Virtual Appointments Available

Title(s): Ophthalmologist; Retina Specialist; Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Vitreoretinal diseases and surgery, medical retina, lasers, pediatric retina, diabetic eye disease

View Full Profile for Caroline R. Baumal, MD

Christopher Robinson, MD

Christopher Robinson, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Director, New England Eye Center-Cambridge; Medical Retina Specialist; Comprehensive Ophthalmologist; Assistant Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Medical retina and comprehensive ophthalmology

View Full Profile for Christopher Robinson, MD

Research + Clinical Trials


OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)

1. Men or women ≥18+ years of age with type 1 or 2 diabetes mellitus who have moderately severe to severe Non-proliferative Diabetic Retinopathy 2. Treatment-naïve (ie, no previous anti-VEGF or steroid treatment or PRP or laser within 1,000 μm of the foveal center/treatment for macular edema or DR in the study eye) 3. Willing and able to return for all study visits and comply with study-related procedures
More information about research and clinical trials